Mati Fridkin
Rehovot, M 76100, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Albumin-Methotrexate Prodrug Analogues That Undergo Intracellular Reactivation Following Entrance into Cancerous Glioma Cells.
Journal: Pharmaceutics
Published: November 30, 2021
Albumin-EDTA-Vanadium Is a Powerful Anti-Proliferative Agent, Following Entrance into Glioma Cells via Caveolae-Mediated Endocytosis.
Journal: Pharmaceutics
Published: July 04, 2021
Therapeutic Potential of Vasoactive Intestinal Peptide and its Derivative Stearyl-Norleucine-VIP in Inflammation-Induced Osteolysis.
Journal: Frontiers in pharmacology
Published: December 05, 2020
Converting bleomycin into a prodrug that undergoes spontaneous reactivation under physiological conditions.
Journal: Toxicology and applied pharmacology
Published: July 14, 2019
The therapeutic potential of tuftsin-phosphorylcholine in giant cell arteritis.
Journal: Journal of autoimmunity
Published: September 27, 2018
Helminth-Based Product and the Microbiome of Mice with Lupus.
Journal: mSystems
Published: August 10, 2018
Tuftsin-phosphorylcholine (TPC) equally effective to methylprednisolone in ameliorating lupus nephritis in a mice model.
Journal: Clinical and experimental immunology
Published: February 12, 2018
Tuftsin-Phosphorylcholine Maintains Normal Gut Microbiota in Collagen Induced Arthritic Mice.
Journal: Frontiers in microbiology
Published: February 23, 2017
Novel therapeutic compound tuftsin-phosphorylcholine attenuates collagen-induced arthritis.
Journal: Clinical and experimental immunology
Published: November 01, 2015
Successful modulation of murine lupus nephritis with tuftsin-phosphorylcholine.
Journal: Journal of autoimmunity
Published: February 02, 2015
Last Updated: 09/26/2026